CGBio starts first clinical trial for next-generation stent for coronary artery
CGBio(CEO Hyun-Seung Yoo) announced after the Ministry of Food and Drug Safety(MOHW) approved the clinical trial plan of drug-eluting stent for coronary artery, Professor Hyo-Soo Kim’s research team at Seoul National University Hospital started the clinical trial for the first time and the proced...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
